title: PR1 peptide vaccine in myeloid malignancies.
authors.forename: Judith A
authors.initials: JA
authors.lastname: Gilbert
mesh_terms: D019496:Cancer Vaccines / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D019337:Hematologic Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006801:Humans; D019272:Leukocyte Elastase / Q000276:immunology; D009842:Oligopeptides / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D044463:Receptor, PAR-1 / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D019496:Cancer Vaccines; D009842:Oligopeptides; C000610686:PAR (protease-activated receptor)-3 receptor, human; D044463:Receptor, PAR-1; D019272:Leukocyte Elastase